N-(2-chloropropyl)-2-pipecoline hydrochloride salt | 3600-49-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: N-(2-chloropropyl)-2-pipecoline hydrochloride salt
• 英文别名: 1-(3-chloropropyl)-2-methylpiperidine hydrochloride；1-(3-Chlor-propyl)-2-methyl-piperidin; Hydrochlorid；1-(3-Chloropropyl)-2-methylpiperidine;hydrochloride
• CAS: 3600-49-5
• 化学式: C₉H₁₈ClN*ClH
• 分子量: 212.163
• InChiKey: OAHPFNRBCBNEQD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.91
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-(2-氟-4-硝基苯氧基)-6-甲氧基-7-羟基喹啉 、 N-(2-chloropropyl)-2-pipecoline hydrochloride salt 在 caesium carbonate 、 potassium iodide 作用下， 以 乙腈 为溶剂， 反应 3.75h， 以83%的产率得到4-(2-fluoro-4-nitrophenoxy)-6-methoxy-7-[3-(2-methylpiperidin-1-yl)propoxy]quinoline
  参考文献：
  名称：

  Discovery of N-[4-(Quinolin-4-yloxy)phenyl]benzenesulfonamides as Novel AXL Kinase Inhibitors

  摘要：

  The overexpression of AXL kinase has been described in many types of cancer. Due to its role in proliferation, survival, migration, and resistance, AXL represents a promising target in the treatment of the disease. In this study we present a novel compound family that successfully targets the AXL kinase. Through optimization and detailed SAR studies we developed low nanomolar inhibitors, and after further biological characterization we identified a potent AXL kinase inhibitor with favorable pharmacokinetic profile. The antitumor activity was determined in xenograft models, and the lead compounds reduced the tumor size by 40% with no observed toxicity as well as lung metastasis formation by 66% when compared to vehicle control.

  DOI：

  10.1021/acs.jmedchem.8b00672

文献信息

• Nitrogenous fused heteroaromatic ring derivative
  申请人：Takahashi Toshiyuki

  公开号：US20070167453A1

  公开（公告）日：2007-07-19

  The invention provides a compound or its pharmaceutically-acceptable salt of formula wherein A 1 is a hydrogen, etc.; j and k are 0 or 1; is a double bond, etc.; is a double bond, etc.; one of W 1 and W 2 is E-O—W, etc., and the other is a hydrogen atom, etc.; E is a divalent group derived from a benzene ring, etc., by removing two hydrogen atoms therefrom; W is a group of formula (II-1): which has a histamine-H3 receptor antagonistic effect or a histamine-H3 receptor inverse-agonistic effect and is useful for prevention or remedy of metabolic system diseases, circulatory system diseases or nervous system diseases.

  本发明提供以下化合物或其药学上可接受的盐：其中A1为氢等；j和k为0或1；为双键等；为双键等；W1和W2中的一个为E-O-W等，另一个为氢原子等；E为由苯环衍生的二价基团，通过从中去除两个氢原子而得到；W为式（II-1）的基团：其具有组织胺H3受体拮抗作用或组织胺H3受体反向激动剂作用，并且对于预防或治疗代谢系统疾病、循环系统疾病或神经系统疾病是有用的。
• NITROGENOUS FUSED HETEROAROMATIC RING DERIVATIVE
  申请人：BANYU PHARMACEUTICAL CO., LTD.

  公开号：EP1719756A1

  公开（公告）日：2006-11-08

  The invention provides a compound or its pharmaceutically-acceptable salt of formula (I): wherein A1 is a hydrogen, etc.; j and k are 0 or 1; is a double bond, etc.; is a double bond, etc.; one of W1 and W2 is E-O-W, etc., and the other is a hydrogen atom, etc.; E is a divalent group derived from a benzene ring, etc., by removing two hydrogen atoms therefrom; W is a group of formula (II-1): which has a histamine-H3 receptor antagonistic effect or a histamine-H3 receptor inverse-agonistic effect and is useful for prevention or remedy of metabolic system diseases, circulatory system diseases or nervous system diseases.

  本发明提供了一种式 (I) 的化合物或其药学上可接受的盐： 其中 A1 是氢等；j 和 k 是 0 或 1； 是双键等； 是双键等 W1和W2中的一个是E-O-W等，另一个是氢原子等；E是从苯环等中去掉两个氢原子而得到的二价基团；W是式(II-1)的基团： W 是式 (II-1) 的基团，具有组胺-H3 受体拮抗作用或组胺-H3 受体逆拮抗作用，可用于预防或治疗代谢系统疾病、循环系统疾病或神经系统疾病。
• The electrochemical fluorination of N-(ω-chloroalkyl)pipecolines and N-(ω-chloroalkyl)hexamethyleneimines
  作者：Eiji Hayashi、Takashi Abe、Hajime Baba、Shunji Nagase

  DOI：10.1016/s0022-1139(00)80969-0

  日期：1984.12
• US7645756B2
  申请人：——

  公开号：US7645756B2

  公开（公告）日：2010-01-12